Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Covance’s CEO Paul Kirchgraber, M.D. has released a letter regarding the company’s name change.
read more
Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery, Fargo, N.D., as its vice president of production and characterization.
read more
AIXIAL, the CRO of ALTEN Group, has announced the acquisition of UK headquartered CMED Group by ALTEN EUROPE.
read more
BioAscent has appointed Dr. Angelo Pugliese as Associate Director of In SilicoDiscovery and Data Analysis to lead the company’s computational chemistry service.
read more
Clinical Ink has announced the hiring of CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso.
read more
Flywheel and Imbio have partnered to accelerate lung disease discovery, diagnosis, and treatment in the Life Sciences.
read more
Syneos Health® has expanded its relationship with Komodo Health.
read more
Albany Molecular Research, Inc. announces expanded access to its accelerated solutions platform, spanning research & development to manufacturing for orphan and rare disease products.
read more
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps forward.
read more
ADMA Biologics, Inc. has announced that the FDA has granted approval for the company’s expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of IVIG.
read more
Catalent and Stirling Ultracold have announced a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.
read more
Lonza has announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna.
read more
Wednesday, April 28, 2021
Avantor Inc. announces that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
read more
Wednesday, April 28, 2021
AavantiBio and Catalent have announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies.
read more
Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine.
read more